Key facts
- It has raised $290K; the latest was Later Stage VC in Jul 2025.
- Notable investors include Bossa Invest, DOMO.VC, ACE Ventures (Commercial Services).
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for VizioMed
- ·The full record, as it builds
Funding rounds
No funding rounds for VizioMed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About VizioMed
Developer of an artificial intelligence-based diagnosis platform designed to provide image-oriented health diagnostics. The company's platform offers sustainable adaptation within the workflows of hospitals and clinics, helping to identify cancer and other serious diseases early through analysis of medical images such as X-rays, mammography, and tomography, enabling healthcare centers to improve treatment by enabling early detection and treatment of diseases.
- Sector
- Healthcare
- HQ
- Recife, Brazil
- Founded
- 2018
- Employees
- 5
- Website
- viziomed.com.br/
- Ownership
- Privately Held (backing)
VizioMed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in VizioMed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on VizioMed in its N-PORT filings yet. We sweep new filings monthly.